CLDF Title
Contact Us | Bookmark
HBV HE HCC HCV
About CLDF Centers of Educational Expertise  
Live CME Meetings Telewebs Webcasts Slide Library Abstract Library Conference Highlights
Featured Programs
Banner2 Banner4 Banner3
 
             
  Liver News - REUTERS   Congress Calendar   Physician Resources  
 
 
High-risk coronary plaque linked to common liver disease
11-06-2014
GSK hepatitis C shot shows promise, bodes well for Ebola vaccines
11-05-2014
Sofosbuvir-ledipasvir effective for relapsed HCV-1
11-03-2014
Individual genetic differences may affect Ebola survival - study
10-30-2014
View Complete News Library
 
 
View all Congresses
 
 
 
 
  Line  
  Featured Abstracts          
 
Ombitasvir (ABT-267), a novel NS5A inhibitor for the treatment of hepatitis C
 
The continuum of hepatitis C testing and care
 
Simeprevir with peginterferon/ribavirin for treatment of chronic hepatitis C virus genotype 1 infection: pooled safety analysis from Phase IIb and III studies
 
Pharmacokinetics, safety, and tolerability of faldaprevir in patients with renal impairment
 
Cirrhosis in hepatitis C virus-infected patients: a review for practitioners new to hepatitis C care
 
Chemotherapy-related reactivation of hepatitis B infection: Updates in 2013
 
 
Combination versus sequential monotherapy in chronic HBV infection: a mathematical approach
 
Combination therapy of interferon and nucleotide/nucleoside analogues for chronic hepatitis B
 
Non-invasive assessment of liver fibrosis in chronic hepatitis B
 
Hepatitis A and B immunity and vaccination in chronic hepatitis B and C patients in a large United States cohort
 
Rifaximin: A Review of Its Use in Reducing Recurrence of Overt Hepatic Encephalopathy Episodes
 
Prolonged remission from hepatic encephalopathy with rifaximin: results of a placebo crossover analysis
 
 
FOUR Score, a Reliable Score for Assessing Overt Hepatic Encephalopathy in Cirrhotic Patients
 
MELD score and antibiotics use are predictors of length of stay in patients hospitalized with hepatic encephalopathy
 
Metformin does not improve survival in patients with hepatocellular carcinoma
 
Combination Therapy With Sorafenib and Radiofrequency Ablation for BCLC Stage 0-B1 Hepatocellular Carcinoma: A Multicenter Retrospective Cohort Study
 
Systemic Therapy for Hepatocellular Carcinoma: The Issue of Treatment Stage Migration and Registration of Progression Using the BCLC-Refined RECIST
 
Clinical outcomes of chronic hepatitis C patients related to baseline liver fibrosis stage - a hospital based linkage study
 
 
          View All Abstracts  
  Line  
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
Live CME Meetings
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Live CME Meetings
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Regional Map
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2014 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.